Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021
HomeTeleflex IncorporatedArrow Seldinger Arterial Catheterization Device Receives FDA Market Clearance

Arrow Seldinger Arterial Catheterization Device Receives FDA Market Clearance

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced today that its Arrow Seldinger Arterial Catheterization Device received market clearance from the U.S. Food and Drug Administration (FDA).

The new Arrow Seldinger Arterial Catheterization Device is indicated for short-term use. The device is designed to improve patient safety by eliminating confusion of catheter identification, reduce risk of complications associated with insertion technique, and provide optimal diagnostics leading to effective treatment for patients. Multiple sizes are available to provide customization to each patient, each insertion site, and each application.

“As we continue to discover new and innovative solutions, the Seldinger Arterial Catheterization Device is now part of our extensive arterial offering in the U.S. market,” said Jake Newman, Vice President and General Manager of Teleflex’s Vascular Access Division. “This innovative device is intended to facilitate ease of insertion and resistance to body collapse1.”

Teleflex expects to launch the Arrow® Seldinger Arterial Catheterization Device in the United States this year.

n our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

References:
1. Teleflex. Seldinger Arterial Catheter Benchtop Studies. Data on File, D011453: 2014.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

By using this website you agree to accept Medical Device News Magazine Privacy Policy